BGI, founded in 1999 with the vision of using genomics to benefit the human race, is now the world’s largest genomics organisation. BGI includes private non-profit research institutes and sequencing application commercial units.

BGI also offers a wide portfolio of genetic screening tests, which are available to clincial partners worldwide. Together with its affiliated offshoots, BGI Americas and BGI Europe, BGI has established partnerships and collaborations with leading academic and government research institutions as well as global biotechnology and pharmaceutical companies, to support a variety of healthcare, agricultural, environmental and related applications.

Through a combination of high-throughput, cost-effective genomics platforms, its large sample collection and storage capability, in-depth bioinformatics analysis and a core commitment to education, BGI is dedicated to ensuring that omics science and technology can be made to work for the benefit of everyone.



pdf-icon pdf-icon pdf-icon
BGI Global Test Portfolio Final  | From Multi-omics Research to Drug RD  | Human Disease Research in Era of NGS